Promoting safe use of vincristine sulfate.
Slimowitz
R
R
D002985:Clinical Protocols; D004348:Drug Labeling; D006801:Humans; D007278:Injections, Spinal / Q000009:adverse effects; D008508:Medication Errors; D014750:Vincristine / Q000008:administration & dosage* / Q000009:adverse effects
D014750:Vincristine